Concepedia

Publication | Open Access

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma

DOIFull Paper Access

26

Citations

9

References

2018

Year

Chia-Jui Yen, Tae‐You Kim, Yin‐Hsun Feng, Yee Chao, Deng‐Yn Lin, Baek‐Yeol Ryoo, Dennis Huang, David Schnell, Julia Hocke, Arsène‐Bienvenu Loembé,
Liver Cancer

Abstract

Nintedanib showed numerically similar efficacy to sorafenib for CIR TTP and OS in Asian patients with advanced HCC and adequate liver function. AEs were generally manageable.

References

YearCitations

Page 1